Journals / Turkish Journal of Immunology / 2020 / Cilt: 8 - Sayı: 3

Cytokine Secretion and Proliferative Capacity of CD4+ T Cells in Delayed Type Hypersensitivity Reactions due to Ciprofloxacin

Siprofloksasine Bağlı Geç Tip Aşırı Duyarlılık Reaksiyonlarında CD4+ T Hücrelerinin Sitokin Salınımları ve Proliferatif Kapasiteleri

Pages
120–128
Publication Date
2022-11-06
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The cell culture supernatants revealed downregulated IL-10 (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Introduction: Ciprofloxacin (CPFX), a frequently prescribed quinolone, may induce cutaneous adverse drug reactions.
📊
Key Findings & Data:This study aimed to evaluate potential value of lymphocyte transformation test (LTT) and intracellular cytokine secretion of drug stimulated CD4+ T cells in patients with DTHR against ciprofloxacin.
💡
Conclusion & Impact:The cell culture supernatants revealed downregulated IL-10 (p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Introduction: Ciprofloxacin (CPFX), a frequently prescribed quinolone, may induce cutaneous adverse drug reactions. Delayed type hypersensitivity reactions (DTHR) are often difficult to deal with, therefore, in vitro testing for DTHR is the long-anticipated method for their management. This study aimed to evaluate potential value of lymphocyte transformation test (LTT) and intracellular cytokine secretion of drug stimulated CD4+ T cells in patients with DTHR against ciprofloxacin. Material and Methods: Patients experienced DTHR with CPFX (n=8) and healthy subjects (n=10) were enrolled. CPFX skin prick, patch and intradermal tests were performed. LTT by flow cytometry aimed to determine CPFXspecific CD4+ T cell proliferation. Intracellular IL-4, IL-10, IL-2 & IFN-γ levels were analysed by flow cytometry in CPFX-specific CD4+T cells. Cytokine contents of cell culture supernatants were evaluated by ELISA. Results: In patients with DTHR, 5 and 10 μg/mL CPFX induced significant CD4+T cell proliferation (p=0.014 and p=0.05, respectively). IL-2 (p=0.02, p=0.001 and p=0.001, respectively) and IL-4 (p=0.001) secreting CD4+T cell percentages were increased, while IFN-γ+(p=0.001, p=0.011 and p=0.012, respectively) and IL-10+(p=0.001, p=0.001 and p=0.002, respectively) CD4+T cells were decreased. The cell culture supernatants revealed downregulated IL-10 (p

Özet

Giriş: Siprofloksasin (SPFX), en yaygın kullanılan kinolon grubu antibiyotiklerden olup, kutanöz ters ilaç reaksiyonları oluşturabilme kapasitesine sahiptir. Gecikmiş tip aşırı duyarlılık reaksiyonlarında (ADR) kesin tanı konulması zor olmakla beraber in vitro tanı testlerinin geç tip ilaç ADR’de kullanımı önemlidir. Çalışmamızda SPFX’e bağlı geç tip ADR geçiren hastalarda, ilaçlar ile uyarılmış CD4+T hücrelerinde, hücre içi sitokin üretimleri ve lenfosit transformasyon (LTT) yanıtları araştırılmıştır. Gereç ve Yöntemler: Çalışmaya SPFX ile geç tip hipersensitivite reaksiyonu (n=8) geçiren hastalar ve sağlıklı kontroller (n=10) dâhil edilmiş, intradermal testler ve yama testleri uygulanmıştır. LTT metodu ile SPFX’e özgül CD4+T hücre proliferasyonu belirlenmiştir. SPFX’e özgül CD4+T hücrelerinde hücre içi IL-4, IL-10, IL-2 ve IFN-γ düzeyleri akan hücre ölçer kullanımı ile değerlendirilmiştir. Kültür üst sıvılarındaki sitokin düzeyleri ELISA aracılığı ile ölçülmüştür. Bulgular: Geç tip ADR geçiren hastalarda 5 ve 10 µg/ml SPFX uyarımı CD4+T hücre proliferasyonunu arttırmıştır (p=0.014 ve p=0.05, sırasıyla). IL-2 (p=0.02, p=0.001 ve p=0.001, sırasıyla) ve IL-4 (p=0.001) salgılayan CD4+T hücre yüzdesi artmasına rağmen IFN-γ+(p=0.001, p=0.011 ve p=0.012, sırasıyla) ve IL-10+(p=0.001, p=0.001 ve p=0.002, sırasıyla) CD4+T hücre oranları azalmıştır. Hücre kültür üst sıvılarında SPX uyarımından bağımsız olarak, hastalarda IL-10 düzeyi (p

🔖

Cite This Article

ÇETİN, E. A., DEMİR, S., ÖZYİĞİT, L. P., DENİZ, G., ERTEK, B., KÜÇÜKSEZER, U. C., GELİNCİK, A., BÜYÜKÖZTÜRK, S. (2022). Cytokine Secretion and Proliferative Capacity of CD4+ T Cells in Delayed Type Hypersensitivity Reactions due to Ciprofloxacin. Turkish Journal of Immunology, Cilt: 8 - Sayı: 3, 120–128. https://ajindex.com/articles/607177

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Van Bambeke F, Tulkens PM. Safety profile of the respiratory fluoroquinolone moxifloxacin: comparison with other fluoroquinolones and other antibacterial classes. Drug Saf 2009;32:359–78
  2. Dona I, Blanca-Lopez N, Torres MJ, Garcia-Campos J, GarciaNunez I, Gomez F, et al. Drug hypersensitivity reactions: response patterns, drug involved, and temporal variations in a large series of patients. J Investig Allergol Clin Immunol 2012;22:363–71.
  3. Kulthanan K, Chularojanamontri L, Manapajon A, Dhana N, Jongjarearnprasert K. Cutaneous adverse reactions to fluoroquinolones. Dermatitis 2011;22:155–60
  4. Lapi F, Tuccori M, Motola D, Pugi A, Vietri M, Montanaro N, et al. Safety profile of the fluoroquinolones: analysis of adverse drug reactions in relation to prescription data using four regional pharmacovigilance databases in Italy. Drug Saf 2010;33:789–99
  5. Neuman MG, Cohen LB, Nanau RM. Quinolones-induced hypersensitivity reactions. Clin Biochem 2015;48:716–39
  6. Blanca-Lopez N, Ariza A, Dona I, Mayorga C, Montanez MI, Garcia-Campos J, et al. Hypersensitivity reactions to fluoroquinolones: analysis of the factors involved. Clin Exp Allergy 2013;43:560–7
  7. Schmid DA, Depta JP, Pichler WJ. T cell-mediated hypersensitivity to quinolones: mechanisms and cross-reactivity. Clin Exp Allergy 2006;36:59–69
  8. Fernandez-Rivas M. Fixed drug eruption (FDE) caused by norfloxacin. Allergy 1997;52:477–8
  9. Lozano Ayllon M, Gomez Martinez M, Mosquera MR, Laguna Martinez JJ, Orta Martiartu M, Fernandez de Miguel C. Fixed eruption caused by ciprofloxacin without cross-sensitivity to norfloxacin. Allergy 1995;50:598–9
  10. Garcia Rodriguez R, Galindo Bonilla PA, Feo Brito FJ, Gomez Torrijos E, Borja Segade J, Lara de la Rosa P, Jiménez AC. Chronic desensitization to quinolones in fixed drug eruption. J Investig Allergol Clin Immunol 2011;21:76–80. http://www.jiaci.org/ issues/vol21issue01/13-16.pdf 11. Davila G, Ruiz-Hornillos J, Rojas P, De Castro F, Zubeldia JM. Toxic epidermal necrolysis induced by levofloxacin. Ann Allergy Asthma Immunol 2009;102:441–2
  11. Blanca-Lopez N, Andreu I, Torres Jaen MJ. Hypersensitivity reactions to quinolones. Current opinion in allergy and clinical immunology. 2011;11(4):285-91 13. Lochmatter P, Zawodniak A, Pichler WJ. In vitro tests in drug hypersensitivity diagnosis. Immunol Allergy Clin North Am 2009;29:537–54
  12. Pichler WJ, Tilch J. The lymphocyte transformation test in the diagnosis